Preliminary Findings Concerning the Use of Prazosin for the Treatment of Posttraumatic Nightmares in a Refugee Population
Authors:
- Lorin BoyntonLBLorin Boynton
- Jacob BentleyJBJacob Bentley
- Eric StrachanESEric Strachan
- Anna BarbatoABAnna Barbato
- Murray RaskindMRMurray Raskind
- 1 November 2009
- journal article
- case report
- Published by Wolters Kluwer Health in Journal of Psychiatric Practice
- Vol. 15 (6) , 454-459
Abstract
Prazosin, a centrally active alpha-1 adrenergic receptor antagonist, has reduced nightmares and sleep disturbances in placebo-controlled studies involving patients with combat and civilian related posttraumatic stress disorder (PTSD). In this retrospective chart review, we analyzed data from 23 refugees diagnosed with chronic PTSD who were treated with prazosin. The recurrent distressing dreams item of the Clinician Administered PTSD Scale (CAPS) was used to quantify nightmare severity. A Clinical Global Impressions-Change (CGI-C) score assessed change in overall PTSD severity exclusive of nightmares. Using a paired-samples t-test, we found that CAPS scores decreased significantly (p <0.0005) from baseline after 8 weeks of treatment with a stable dose of prazosin. Overall PTSD severity was "markedly improved" in 6 patients, "moderately improved" in 11 patients, and "minimally improved" in 6 patients. These data provide preliminary support for the use of prazosin in targeting reduction of trauma-related nightmares and promoting improvement of global clinical status within an international sample of severely traumatized refugee patients.Keywords
This publication has 15 references indexed in Scilit:
- Nonnightmare distressed awakenings in veterans with posttraumatic stress disorder: Response to prazosinJournal of Traumatic Stress, 2008
- Prazosin Effects on Objective Sleep Measures and Clinical Symptoms in Civilian Trauma Posttraumatic Stress Disorder: A Placebo-Controlled StudyBiological Psychiatry, 2008
- A Parallel Group Placebo Controlled Study of Prazosin for Trauma Nightmares and Sleep Disturbance in Combat Veterans with Post-Traumatic Stress DisorderBiological Psychiatry, 2007
- The Use of Prazosin for the Treatment of Trauma Nightmares and Sleep Disturbance in Combat Veterans with Post-Traumatic Stress DisorderBiological Psychiatry, 2007
- Pharmacologic Reduction of CNS Noradrenergic Activity in PTSD: The Case for Clonidine and PrazosinJournal of Psychiatric Practice, 2007
- Cognitive-behavior therapy vs exposure therapy in the treatment of PTSD in refugeesBehaviour Research and Therapy, 2001
- Sleep disturbances and psychiatric disorders associated with posttraumatic stress disorder in the general populationComprehensive Psychiatry, 2000
- The alpha1-Adrenergic Antagonist Prazosin Ameliorates Combat Trauma Nightmares in Veterans With Posttraumatic Stress DisorderThe Journal of Clinical Psychiatry, 2000
- The development of a clinician‐administered PTSD scaleJournal of Traumatic Stress, 1995
- Prazosin selectively antagonizes neuronal responses mediated by ?1-adrenoceptors in brainNaunyn-Schmiedeberg's Archives of Pharmacology, 1981